 |
|
A Comparative Study of Eight Fecal Occult Blood Tests and HemoQuant in Patients in Whom Colonoscopy Is Indicated
N. Gopalswamy, MD;
Herbert P. Stelling, MD;
Ronald J. Markert, PhD;
Henry N. Maimon, MD;
Sheri D. Wahlen, MD;
Richard I. Haddy, MD
Arch Fam Med. 1994;3(12):1043-1048.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Gabrielsson N, Granqvist S, Nilsson B. Guaiac tests for detection of occult faecal blood loss in patients with endoscopically verified colonic polyps. Scand J Gastroenterol. 1985;20:978-982.
PUBMED
2. Adlercreutz H, Liewendahl K, Virkola P. Evaluation of Fecatest, a new guaiac test for occult blood in feces. Clin Chem. 1978;24:756-761.
FREE FULL TEXT
3. Bertario L, Spinelli P, Gennari L, et al. Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci. 1988;33:609-613.
PUBMED
4. Pye G, Jackson J, Thomas WM, Hardcastle JD. Comparison of Coloscreen selftest and HemoccultR faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg. 1990;77:630-631.
PUBMED
5. Stelling HP, Maimon H, Smith RA, Bigley NJ, Mukherjee MD. New screening method for occult gastrointestinal bleeding: immunologic and guaiac slide tests. J Fam Pract. 1984;19:757-761.
PUBMED
6. Tate JJT, Northway J, Royle GT, Taylor I. Fecal occult blood testing in symptomatic patients: comparison of three tests. Br J Surg. 1990;77:523-526.
PUBMED
7. Adelcreutz H, Partanen P, Virkola P, Liewendahl K, Turunen MJ. Five guaiacbased tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest. 1984;44:519-528.
PUBMED
8. Leicester RJ, Lightfoot A, Millar J, Colli-Jones DG. Accuracy and value of the Hemoccult test in symptomatic patients. BMJ. 1983;286:673-674.
FREE FULL TEXT
9. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity, and predictive value: long-term follow-up in a large group practice setting. Ann Intern Med. 1990;112:328-333.
FREE FULL TEXT
10. Stelling HP, Maimon HN, Smith RA, Haddy RI, Markert RJ. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology. Arch Intern Med. 1990;150:1001-1005.
FREE FULL TEXT
11. Ahlquist DA, Klee GG, McGill DB, Ellefson RD. Colorectal cancer detection in the practice setting: impact of fecal blood testing. Arch Intern Med. 1990;150:1041-1045.
FREE FULL TEXT
12. St. John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993;104:1661-1668.
PUBMED
13. Barrows GH, Burton RM, Jarrett DD, Russell GG, Alford MD, Songster CL. Immunochemical detection of human blood in feces. Am J Clin Pathol. 1978;69:342-346.
PUBMED
14. Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood—the fecal smear punch-disk test: a new non-invasive screening test for colorectal cancer. Cancer. 1980;45:1099-1102.
PUBMED
15. Turunen MJ, Liewendahl K, Partanen P, Adelcreutz H. Immunological detection of fecal occult blood in colorectal cancer. Br J Cancer. 1984;49:141-148.
PUBMED
16. Saito H, Tsuchida S, Nakali S, et al. An immunochemical test for fecal occult blood by countercurrent immunoelectrophoresis. Cancer. 1985;56:1549-1552.
PUBMED
17. McDonald C, Buford Y, Walls R, Coulston K. Immunochemical testing for fecal occult blood in patients with colorectal cancer. Med J Australia. 1985;143:141-143.
PUBMED
18. Armitage N, Hardcastle JD, Amar SS, Haynes J, James PD. A comparison of an immuno-chemical faecal occult blood test Fecatwin sensitive/FECA-EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer. 1985;51:799-804.
PUBMED
19. Ranshoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. JAMA. 1990;264:76-78.
FREE FULL TEXT
20. Herzog P, Holtermueller KH, Preiss J, et al. Fecal blood loss in patients with colonic polyps: comparison of measurements with 51chromium-labelled erythrocytes and with the Haemoccult test. Gastroenterology. 1982;83:957-962.
PUBMED
21. Heinrich HC, Icagic F. Comparative studies on the 'in vivo' sensitivity of four commercial pseudoperoxidase-based fecal occult blood tests in relation to actual blood losses as calculated from measured whole body 59Fe-elimination rates. Clin Wochenschr. 1980;58:1283-1297.
22. Leahy MBG, Pippard MJ, Salzmann MB, et al. Quantitative measurement of fecal blood loss: comparison of radioisotopic and chemical analysis. J Clin Pathol. 1991;44:391-394.
FREE FULL TEXT
23. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA. 1993;269:1262-1267.
FREE FULL TEXT
24. Neugut Al, Garbowski GC, Waye JD, et al. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol. 1993;88:1179-1183.
PUBMED
25. Young GP, St. John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. In: Rozen P, Reich CB, Winawer SJ, eds. Frontiers in Gastrointestinal Research. Basel, Switzerland: Karger; 1991:135-156. 26. Thomas WM, Hardcastle JD. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut. 1990;31:1294-1297.
FREE FULL TEXT
27. Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184-1187.
PUBMED
|
